Literature DB >> 10853976

'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.

M M Lederman1, L A Kalish, D Asmuth, E Fiebig, M Mileno, M P Busch.   

Abstract

OBJECTIVE: To model the relationships among HIV-1 replication, immune activation and CD4+ T-cell losses in HIV-1 infection.
METHODS: Cross-sectional analysis of baseline data from the Viral Activation by Transfusion Study. Comparisons of unadjusted and adjusted correlative analyses to establish models for mechanisms of cell loss in AIDS.
RESULTS: Using these analyses, significant correlations were found among plasma levels of tumor necrosis factor alpha (TNFalpha) and its type two receptor (TNFrII), interleukin-6 (IL-6), beta2-microglobulin, expression of CD38 and HLA-DR on CD8+ T lymphocytes and plasma levels of HIV-1 RNA. When correlations among these indices were adjusted for possible intermediary correlations, the relationship between HIV-1 RNA levels and all plasma markers of immune activation could be accounted for by the correlation between plasma HIV-1 RNA and plasma TNFrII levels. In addition, the negative correlations that both HIV-1 RNA levels and TNFrII levels had with CD4+ T-cell counts were partially accounted for by the correlations of HIV-1 RNA and TNFrII with CD38 expression on CD8+ T cells. In persons with advanced disease (CD4+ T cells < 50 x 10(6)/l) IL-6 levels were inversely correlated with CD4+ T-cell counts.
CONCLUSIONS: This analysis is consistent with a model wherein HIV-1 replication induces TNFalpha expression that induces multiple other indices of immune activation. In this model, HIV-1 replication and TNFalpha expression induce CD4+ T-cell losses at least in part through mechanisms reflected in heightened CD38 expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853976     DOI: 10.1097/00002030-200005260-00006

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  19 in total

Review 1.  Serological markers of disease activity in tuberculosis and HIV infection.

Authors:  A Marchant
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.

Authors:  Adriana A Byrnes; David M Harris; Sowsan F Atabani; Beulah P Sabundayo; Susan J Langan; Joseph B Margolick; Christopher L Karp
Journal:  J Leukoc Biol       Date:  2008-09-19       Impact factor: 4.962

3.  Discordance between peripheral and colonic markers of inflammation during suppressive ART.

Authors:  Richard M Dunham; Ivan Vujkovic-Cvijin; Steven A Yukl; Mara J Broadhurst; Pʼng Loke; Rebecca G Albright; Joseph K Wong; Michael M Lederman; Ma Somsouk; Peter W Hunt; Jeffrey N Martin; Steven G Deeks; Joseph M McCune
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

4.  Plasma cytokine levels are related to brain volumes in HIV-infected individuals.

Authors:  Assawin Gongvatana; Stephen Correia; Shira Dunsiger; Lynne Gauthier; Kathryn N Devlin; Skye Ross; Bradford Navia; Karen T Tashima; Suzanne DeLaMonte; Ronald A Cohen
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-02       Impact factor: 4.147

5.  Haemoglobin and anaemia in the SMART study.

Authors:  Amanda Mocroft; Alan R Lifson; Giota Touloumi; Jacqueline Neuhaus; Zoe Fox; Adrian Palfreeman; Michael J Vjecha; Sally Hodder; Stephane De Wit; Jens D Lundgren; Andrew N Phillips
Journal:  Antivir Ther       Date:  2011

Review 6.  Study design issues in evaluating immune biomarkers.

Authors:  Ronald J Bosch; Xinyan Zhang; Netanya G Sandler
Journal:  Curr Opin HIV AIDS       Date:  2013-03       Impact factor: 4.283

7.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

8.  Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients.

Authors:  David Eric Ouedraogo; Alain Makinson; Nils Kuster; Nicolas Nagot; Pierre-Alain Rubbo; Karine Bollore; Vincent Foulongne; Guillaume Cartron; Daniel Olive; Jacques Reynes; Jean-Pierre Vendrell; Edouard Tuaillon
Journal:  J Clin Immunol       Date:  2012-08-23       Impact factor: 8.317

9.  Role of immune activation in CD4+ T-cell depletion in HIV-1 infected Indian patients.

Authors:  M Vajpayee; S Kaushik; V Sreenivas; K Mojumdar; S Mendiratta; N K Chauhan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-09       Impact factor: 3.267

10.  Associations of Circulating Soluble Tumor Necrosis Factor-α Receptors 1 and 2 with Interleukin-6 Levels in an Aging Cohort of Injection Drug Users with or at High Risk for HIV Infection.

Authors:  Sean X Leng; Stewart Dandorf; Huifen Li; Joshua Carlson; Jessica Hui; Shruti H Mehta; Damani Piggott; Salequl Islam; Bhavish Manwani; Gregory D Kirk
Journal:  AIDS Res Hum Retroviruses       Date:  2015-10-13       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.